VENUS REMEDIES LTD. - 526953 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance report as on 31st March 2024.13-05-2024
13-05-2024
VENUS REMEDIES LTD. - 526953 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyVENUS REMEDIES LTD. 2CIN NO.L24232CH1989PLC009705 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Neha Designation: Company Secretary and Compliance officer EmailId: [email protected] Name of the Chief Financial Officer: Pawan Chaudhary Designation: CFO EmailId: [email protected] Date: 22/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.22-04-2024
VENUS REMEDIES LTD. - 526953 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance under Reg 74(5) of SEBI(DP) regulations for the period ended on 31st March 2024.08-04-2024
VENUS REMEDIES LTD. - 526953 - Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Compliance under regulation 7(3) of SEBI (LODR) Reg 2015, for the period ended on 31st March 2024.08-04-2024
VENUS REMEDIES LTD. - 526953 - Compliance Under Reg 40(10) For The Year Ended On 31St March 2024
Compliance under reg 40(10) of SEBI (LODR) for the period ended on 31.03.2024.06-04-2024
VENUS REMEDIES LTD. - 526953 - Venus Remedies Awarded With Rs. 2.50 Crore As The Remaining Part Of Its First Incentive Under The PLI Scheme.(Revised Update)
Venus Remedies awarded with Rs.2.50cr as the remaining part of its first incentive under PLi scheme.01-04-2024
VENUS REMEDIES LTD. - 526953 - Venus Remedies Awarded With Rs.2.50 Crores As The Remaining Part Of Its First Incentive Under The PLI Scheme.
Venus Remedies awarded with Rs.2.50crores as the remaining part of its first incentive under PLI scheme.01-04-2024
VENUS REMEDIES LTD. - 526953 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Stop Transfer for loss of shares certificate.29-03-2024
Venus Remedies Bags Approvals To Market Three Cancer Drugs In Ukraine
With over two decades of presence in the Ukrainian market, the company has 57 product registrations in Ukraine.18-03-2024